Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Omnibus Spending Package Awards $102M More To US FDA, But Drops COVID-19 Funding

Executive Summary

The Congressional spending bill is being voted on this week and includes $14bn in emergency aid to Ukraine.

You may also be interested in...



Senate Proposes Smaller Boost Than House For FDA FY2023 Appropriation

A  proposed budget from the US Senate appropriations committee would fund the FDA's device activities at $663m for fiscal 2023, marking a modest increase from 2022 but a drop from House and administration requests. 

HHS Decision to End Free COVID-19 Testing Will Hurt Uninsured And Could Increase Infection Rates, Survey Finds

Research from LendingTree finds the end to government coverage of COVID-19 tests for the uninsured will result in less testing and a potential spike in new cases.

House Extends Telehealth Benefits In Massive Spending Bill, Sends To Senate

The US House has extended to Medicare recipients temporary waivers for telehealth coverage that was put in place at the onset of the COVID-19 pandemic. The legislation now moves to the Senate where it’s also expected to pass.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT145176

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel